https://vitalspanwire.com/news/orthopaedic-peptide-therapy-evidence-mapVitalspan Wireen2026-08-16T10:30:00.000ZOrthopaedic peptide therapy spans approved bone drugs and unproven regeneration claimshttps://vitalspanwire.com/news/idr-1002-peptide-inflamed-dental-pulp-repairVitalspan Wireen2026-08-16T09:45:00.000ZAn immune-regulating peptide combines antibacterial and repair signals in inflamed dental pulphttps://vitalspanwire.com/news/peptide-mhc-t-cell-engager-solid-tumors-miceVitalspan Wireen2026-08-16T09:00:00.000ZA peptide-MHC engager recruits selected T cells against solid tumors in micehttps://vitalspanwire.com/news/mettl3-targeting-peptide-lung-cancer-cellsVitalspan Wireen2026-08-16T08:15:00.000ZA METTL3-targeting peptide disrupts an RNA-modifying complex in lung cancer cellshttps://vitalspanwire.com/news/aurora-a-peptide-prostate-cancer-cells-in-vitroVitalspan Wireen2026-08-16T07:30:00.000ZAurora-A peptide slows prostate cancer cells in vitro; the target is not yet a therapyhttps://vitalspanwire.com/news/self-assembling-nrf2-peptide-retina-mouse-modelVitalspan Wireen2026-08-16T06:45:00.000ZA self-assembling peptide reaches deep retinal tissue in a mouse degeneration modelhttps://vitalspanwire.com/news/intranasal-alarin-weight-loss-rats-evidence-checkVitalspan Wireen2026-08-16T06:00:00.000ZIntranasal alarin reduces weight in rats, far upstream of a human obesity drughttps://vitalspanwire.com/news/amy-101-complement-c3-nmosd-mouse-modelVitalspan Wireen2026-08-16T05:15:00.000ZComplement-blocking peptide AMY-101 protects tissue in an NMOSD mouse modelhttps://vitalspanwire.com/news/semaglutide-lactam-stapled-glp1-scaffoldsVitalspan Wireen2026-08-16T04:30:00.000ZResearchers staple semaglutide fragments to build tougher GLP-1 scaffoldshttps://vitalspanwire.com/news/peptisleep-pilot-sleep-signals-not-verdictVitalspan Wireen2026-08-16T03:45:00.000ZA 26-person sleep-peptide pilot reports signals—not a verdicthttps://vitalspanwire.com/news/ai-antimicrobial-peptide-design-validation-bottleneckVitalspan Wireen2026-08-16T03:00:00.000ZAI can propose antimicrobial peptides faster; biological validation remains the bottleneckhttps://vitalspanwire.com/news/compete-edotreotide-everolimus-neuroendocrine-tumorsVitalspan Wireen2026-08-16T02:15:00.000ZRadiolabeled peptide therapy beats everolimus on progression-free survival in COMPETEhttps://vitalspanwire.com/news/apitegromab-lean-mass-tirzepatide-phase-2Vitalspan Wireen2026-08-16T01:30:00.000ZA muscle-preservation trial tests what is lost alongside tirzepatide weighthttps://vitalspanwire.com/news/petrelintide-phase-1-long-acting-amylin-weight-lossVitalspan Wireen2026-08-16T00:45:00.000ZPetrelintide’s phase 1 data put a long-acting amylin analogue into the weight-loss racehttps://vitalspanwire.com/news/il-17a-peptide-vaccine-first-human-safety-studyVitalspan Wireen2026-08-16T00:00:00.000ZAn adjuvant-free IL-17A peptide vaccine clears its first human safety studyhttps://vitalspanwire.com/stories/compounded-drugs-approval-explainerVitalspan Wireen2026-08-15T17:00:00-04:00What 'compounded' means—and what it does not mean